KERRY YAKAWIAK: Open Payments
NPI 1265509293 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 26 payments from 10 companies in 2025. Trend: 2023 $548 · 2024 $475 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $189 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $92 |
| Abbott Laboratories | 4 | $81 |
| Lilly USA, LLC | 2 | $52 |
| Novo Nordisk Inc | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: AIRSUPRA, JARDIANCE, FREESTYLE LIBRE 3, FARXIGA, MOUNJARO, GVOKE HYPOPEN, Wegovy, BREZTRI.
Industry payments across NY — which companies pay providers there.
